To further understand the underlying molecular mechanism(s) of hepatoprotection and correction of dyslipidemia by B-TCE, the expression of proteins associated with lipid metabolism such as AMPK, ACC, SREBP-1, FAS, HMG-CoAR, and ATGL were studied in the liver tissue. This evidence concerns the gene SREBF1 and metabolic syndrome.